tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Fein, 27 are a HOLD (3.9%), 664 are a BUY (95.95%), 1 are a SELL (0.14%).
Analyst Andrew Fein, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 41.05% that have a potential upside of 62.18% achieved within 192 days.
Andrew Fein’s has documented 1,308 price targets and ratings displayed on 69 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on AMLX, Amylyx Pharmaceuticals at 07-Nov-2025.
Analyst best performing recommendations are on SVRA (SAVARA).
The best stock recommendation documented was for SVRA (SAVARA) at 6/12/2019. The price target of $6 was fulfilled within 1 day with a profit of $4.57 (43.24%) receiving and performance score of 432.36.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 09-May-2024
$29
$2.29 (8.57%)
$24
1 months 5 days ago
(02-Dec-2025)
10/14 (71.43%)
$3.57 (14.04%)
157
Buy
Since 10-Oct-2023
$31
$4.29 (16.06%)
$33
1 months 21 days ago
(17-Nov-2025)
8/14 (57.14%)
$6.98 (29.06%)
113
Buy
Since 28-Feb-2024
$29
$2.29 (8.57%)
$28
2 months 1 days ago
(06-Nov-2025)
5/11 (45.45%)
$7.35 (33.95%)
312
Buy
Since 23-Jun-2025
$32
$5.29 (19.81%)
$40
2 months 1 days ago
(06-Nov-2025)
0/3 (0%)
$10.35 (47.81%)
Buy
Since 07-Aug-2015
$39
$12.29 (46.01%)
$35
3 months 27 days ago
(11-Sep-2025)
7/12 (58.33%)
$14.8 (61.16%)
671
Which stock is Andrew Fein is most bullish on?
Which stock is Andrew Fein is most reserved on?
What Year was the first public recommendation made by Andrew Fein?
